Related Experiment Video
Updated: May 22, 2025

05:23
Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
6.0K
SARS-CoV-2 Nsp13 helicase modulates miR-146a-mediated signaling pathways
Eryn Lundrigan1, Spencer Uguccioni1, Christine Hum1
1Department of Chemistry and Biomolecular Sciences, University of Ottawa, Ottawa, Ontario, K1N 6N5, Canada.
Virology
|March 12, 2025
Summary
The SARS-CoV-2 Nsp13 helicase impacts host cells by upregulating microRNA-146a (miRNA-146a). This impacts inflammation and immune signaling, offering new therapeutic targets for COVID-19 variants.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- SARS-CoV-2 mutations necessitate understanding viral pathogenesis.
- The non-structural protein 13 (Nsp13) helicase is crucial for viral replication.
- Host-pathogen interactions and signaling pathways are key research areas.
Purpose of the Study:
- To investigate the influence of SARS-CoV-2 Nsp13 helicase on host cellular processes.
- To explore Nsp13's role in host gene expression and signaling pathways.
- To identify potential therapeutic targets for COVID-19 variants.
Main Methods:
- Global transcriptomic analysis of Nsp13-transfected A549 cells.
- Bioinformatic analysis to identify relevant microRNA (miRNA) pathways.
- Gene expression analysis of miRNA targets (TRAF6, IRAK1).
Main Results:
- Nsp13 transfection altered pathways involved in post-transcriptional gene silencing and RNA translational repression.
- MicroRNA-146a (miR-146a) was significantly induced in Nsp13-transfected cells.
- Expression of miR-146a targets, TRAF6 and IRAK1, was decreased, impacting NF-kB and IFN signaling.
Conclusions:
- Nsp13 induces miR-146a, modulating host inflammatory and immune responses.
- Nsp13-mediated miR-146a signaling impacts NF-kB and SMAD4 pathways.
- Targeting Nsp13-induced miR-146a pathways may offer novel therapeutic strategies against SARS-CoV-2 variants.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
13.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.8K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
siRNA - Small Interfering RNAs
16.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K

